Key points are not available for this paper at this time.
In Chile, a country with a GDP per capita of USD17, 000, various immunization strategies are cost-saving for scenarios comparable to pre-pandemic 2019 and to the particularly severe 2023 when considering only those direct costs associated with patient care, albeit differing in their impact in health outcomes. The resulting decrease in healthcare strain during the Winter virus surge underscores the strategy's impact.
Sauré et al. (Sat,) studied this question.